Market Access & Value
Accelerating market access for drugs and medical devices
At CMS, we support pharmaceutical companies, biotechs and medical device manufacturers in the market access process. Thanks to our expertise in regulation, medico-economic evaluation and negotiation with health authorities, we facilitate the introduction and reimbursement of your products on various markets.
Medico-Economic Studies and Valuation of Health Products
- Cost-effectiveness and cost-utility analyses
- Economic modeling and budgetary impact of new therapies
- Drafting of Health Technology Assessment (HTA) files
- Generation of Real-World Evidence (RWE) to reinforce medical and economic arguments
Authority relations and tariff negotiations
- Interaction with health authorities and reimbursement commissions
- Support during tariff negotiations with payers and decision-makers
- Development of solid medico-economic arguments to defend the value of the product
- Strategies for differentiation to maximize repayment opportunities
International Market Access and Local Adaptation
- Market research and mapping of healthcare systems by country
- Adaptation of pricing and reimbursement files to local requirements
- Definition of international expansion strategies based on pricing and access policies in different countries
Communication and Training Market Access
- Awareness-raising and training internal teams on Market Access issues
- Preparing arguments for healthcare payers and decision-makers
- Drafting of teaching materials and strategic workshops for product launches